Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets

Journal of Virology

Volumn 88, Issue 9, 2014, Pages 4786-4797

  Ma, Yingfei ^a   Madupu, Ramana ^b   Karaoz, Ulas ^c   Nossa, Carlos W ^d   Yang, Liying ^a   Yooseph, Shibu ^b   Yachimski, Patrick S ^e   Brodie, Eoin L ^c   Nelson, Karen E ^b   Pei, Zhiheng ^a,f  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d Gene by Gene Ltd   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENOME ANALYSIS; HUMAN; INTESTINE; MAJOR CLINICAL STUDY; METAGENOMICS; MOLECULAR PHYLOGENY; MOUTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE DATABASE; SKIN; UNINDEXED SEQUENCE; VAGINA; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS FORMS; VIRUS STRAIN; WART VIRUS;

COINFECTION; FEMALE; HEALTHY VOLUNTEERS; HUMANS; METAGENOMICS; MICROBIOTA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 84897558865     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00093-14     Document Type: Article

References (63)

1. Van Doorslaer K, Tan Q, Xirasagar S, Bandaru S, Gopalan V, Mohamoud Y, Huyen Y, McBride AA. 2013. The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 41:D571-D578. http://dx.doi.org/10.1093/nar/gks984.
2. de Villiers EM. 2013. Cross-roads in the classification of papillomaviruses. Virology 445:2-10. http://dx.doi.org/10.1016/j.virol.2013.04.023.
3. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79. http://dx.doi.org/10.1016/j.virol.2010.02.002.
4. Lee CA. 2012. Human papillomavirus (HPV) and cervical cancer. J. Insur. Med. 43:178-181.
5. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. 2013. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J. Infect. 66:207-217. http://dx.doi.org/10.1016/j.jinf.2012.10.024.
6. Bian ML, Cheng JY, Ma L, Cong X, Liu J, Chen Y, Chen X. 2013. Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening. Exp. Ther. Med. 6:1332-1336. http://dx.doi.org/10.3892/etm.2013.1309.
7. DiMaio D, Liao JB. 2006. Human papillomaviruses and cervical cancer. Adv. Virus Res. 66:125-159. http://dx.doi.org/10.1016/S0065-3527(06) 66003-X.
8. Dell G, Gaston K. 2001. Human papillomaviruses and their role in cervical cancer. Cell. Mol. Life Sci. 58:1923-1942. http://dx.doi.org/10.1007/PL00000827.
9. Sycuro LK, Xi LF, Hughes JP, Feng Q, Winer RL, Lee SK, O'Reilly S, Kiviat NB, Koutsky LA. 2008. Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J. Infect. Dis. 198:971-978. http://dx.doi.org/10.1086/591625.
10. Gillison ML. 2008. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J. Adolesc. Health 43:S52-S60. http://dx.doi.org/10.1016/j.jadohealth.2008.07.002.
11. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. 2012. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 6(Suppl 1):S104-S120. http://dx.doi.org/10.1007/s12105-012-0368-1.
12. Parkin DM. 2006. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118:3030-3044. http://dx.doi.org/10.1002/ijc.21731.
13. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24(Suppl 3):S3/1-S3/10. http://dx.doi.org/10.1016/j.vaccine.2005.01.101.
14. Parkin DM, Bray F. 2006. Chapter 2: the burden of HPV-related cancers. Vaccine 24(Suppl 3):S3/11-S3/25. http://dx.doi.org/10.1016/j.vaccine.20 05.01.101.
15. Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E. 2013. The landscape of viral expression and host gene fusion and adaptation in humancancer. Nat.Commun.4:2513. http://dx.doi.org/10.1038/ncomms 3513.
16. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys Study Group. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991-998. http://dx.doi.org/10.1016/S0140-6736(05)67069-9.
17. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. 2000. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 74:11636-11641. http://dx.doi.org/10.1128/JVI.74.24.11636-11641.2000.
18. Bottalico D, Chen Z, Kocjan BJ, Seme K, Poljak M, Burk RD. 2012. Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches. J. Gen. Virol. 93: 1774-1779. http://dx.doi.org/10.1099/vir.0.041897-0.
19. Johansson H, Bzhalava D, Ekstrom J, Hultin E, Dillner J, Forslund O. 2013. Metagenomic sequencing of "HPV-negative" condylomas detects novel putative HPV types. Virology 440:1-7. http://dx.doi.org/10.1016/j.virol.2013.01.023.
20. Mokili JL, Dutilh BE, Lim YW, Schneider BS, Taylor T, Haynes MR, Metzgar D, Myers CA, Blair PJ, Nosrat B, Wolfe ND, Rohwer F. 2013. Identification of a novel human papillomavirus by metagenomic analysis of samples from patients with febrile respiratory illness. PLoS One 8:e58404. http://dx.doi.org/10.1371/journal.pone.0058404.
21. Kocjan BJ, Steyer A, Sagadin M, Hosnjak L, Poljak M. 2013. Novel human papillomavirus type 174 from a cutaneous squamous cell carcinoma. Genome Announc. 1(4):e00445-13. http://dx.doi.org/10.1128/genomeA.00445-13.
22. Foulongne V, Sauvage V, Hebert C, Dereure O, Cheval J, Gouilh MA, Pariente K, Segondy M, Burguiere A, Manuguerra JC, Caro V, Eloit M. 2012. Human skin microbiota: high diversity ofDNAviruses identified on the human skin by high throughput sequencing. PLoS One 7:e38499. http://dx.doi.org/10.1371/journal.pone.0038499.
23. Li L, Barry P, Yeh E, Glaser C, Schnurr D, Delwart E. 2009. Identifica-tion of a novel human gammapapillomavirus species. J. Gen. Virol. 90: 2413-2417. http://dx.doi.org/10.1099/vir.0.012344-0.
24. Ekstrom J, Bzhalava D, Svenback D, Forslund O, Dillner J. 2011. High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions. Int. J. Cancer 129:2643-2650. http://dx.doi.org/10.1002/ijc.26204.
25. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M. 2009. The NIH Human Microbiome Project. Genome Res. 19:2317-2323. http://dx.doi.org/10.1101/gr.096651.109.
26. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207-214. http://dx.doi.org/10.1038/nature11234.
27. McInnes P, Cutting M. 29 July 2010. Manual of procedures for Human Microbiome Project. Core microbiome sampling protocol A, HMP protocol # 07-001. Version number: 12.0. http://hmpdacc.org/doc/HMP _MOP_Version12_0_072910.pdf.
28. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
29. Friedman J, Alm EJ. 2012. Inferring correlation networks from genomic survey data. PLoS Comput. Biol. 8:e1002687. http://dx.doi.org/10.1371/journal.pcbi.1002687.
30. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27. http://dx.doi.org/10.1016/j.virol.2004.03.033.
31. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M. 2006. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J. Natl. Cancer Inst. 98:389-395. http://dx.doi.org/10.1093/jnci/djj092.
32. Karagas MR, Waterboer T, Li Z, Nelson HH, Michael KM, Bavinck JN, Perry AE, Spencer SK, Daling J, Green AC, Pawlita M. 2010. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 341:c2986. http://dx.doi.org/10.1136/bmj.c2986.
33. Kovanda A, Kocjan BJ, Potocnik M, Poljak M. 2011. Characterization of a novel cutaneous human papillomavirus genotype HPV-125. PLoS One 6:e22414. http://dx.doi.org/10.1371/journal.pone.0022414.
34. Centers for Disease Control and Prevention. 2012. Human papillomavirus: epidemiology and prevention of vaccine-preventable diseases, 12th ed. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html.
35. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. 2007. Prevalence of HPV infection among females in the United States. JAMA 297:813-819. http://dx.doi.org/10.1001/jama.297.8.813.
36. Li J, Pan Y, Xu Z, Wang Q, Hang D, Shen N, Liu M, Zhang C, Abliz A, Deng Q, Cai H, Ke Y. 2013. Improved detection of human papillomavirus harbored in healthy skin with FAP6085/64 primers. J. Virol. Methods 193:633-638. http://dx.doi.org/10.1016/j.jviromet.2013.06.026.
37. Sanchez-Vargas LO, Diaz-Hernandez C, Martinez-Martinez A. 2010. Detection of human papilloma virus (HPV) in oral mucosa of women with cervical lesions and their relation to oral sex practices. Infect. Agents Cancer 5:25. http://dx.doi.org/10.1186/1750-9378-5-25.
38. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR. 2010. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex. Transm. Dis. 37:386-391. http://dx.doi.org/10.1097/OLQ.0b013e3181c94a3b.
39. Esquenazi D, Bussoloti Filho I, Carvalho Mda G, Barros FS. 2010. The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR. Braz. J. Otorhinolaryngol. 76:78-84.
40. Castellsague X, Drudis T, Canadas MP, Gonce A, Ros R, Perez JM, Quintana MJ, Munoz J, Albero G, de Sanjose S, Bosch FX. 2009. Human papillomavirus (HPV) infection in pregnant women and motherto-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect. Dis. 9:74. http://dx.doi.org/10.1186/1471-2334-9-74.
41. Rintala MA, Grenman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjanen SM. 2005. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J. Clin. Microbiol. 43:376-381. http://dx.doi.org/10.1128/JCM.43.1.376-381.2005.
42. Jay N, Moscicki AB. 2000. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read. 10:659-668.
43. Miller CS, White DK. 1996. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 82:57-68. http://dx.doi.org/10.1016/S1079-2104(96) 80378-7.
44. Kellokoski J, Syrjanen S, Yliskoski M, Syrjanen K. 1992. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microbiol. Immunol. 7:19-23. http://dx.doi.org/10.1111/j.1399-302X.1992.tb00014.x.
45. Rautava J, Willberg J, Louvanto K, Wideman L, Syrjanen K, Grenman S, Syrjanen S. 2012. Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One 7:e42171. http://dx.doi.org/10.1371/journal.pone.004 2171.
46. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK, Stisser K, Konig R, Tyring SK. 2004. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J. Virol. Methods 122:87-93. http://dx.doi.org/10.1016/j.jviromet.2004.08.007.
47. Eisen JA. 2007. Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes. PLoS Biol. 5:e82. http://dx.doi.org/10.1371/journal.pbio.0050082.
48. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, Hoang Anh PT, Ferreccio C, Matos E, Posso H, de Sanjose S, Shin HR, Sukvirach S, Lazcano-Ponce E, Ronco G, Rajkumar R, Qiao YL, Munoz N, Franceschi S. 2006. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol. Biomarkers Prev. 15:2148-2153. http://dx.doi.org/10.1158/1055-9965.EPI-06-0556.
49. Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Munoz A. 2005. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 192:1158-1165. http://dx.doi.org/10.1086/444391.
50. Burd EM. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16:1-17. http://dx.doi.org/10.1128/CMR.16.1.1-17.2003.
51. Kocken M, Uijterwaal MH, de Vries AL, Berkhof J, Ket JC, Helmerhorst TJ, Meijer CJ. 2012. High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for highgrade cervical disease: a systematic review and meta-analysis. Gynecol. Oncol. 125:500-507. http://dx.doi.org/10.1016/j.ygyno.2012.01.015.
52. Nishino HT, Tambouret RH, Wilbur DC. 2011. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol. 119:219-227. http://dx.doi.org/10.1002/cncy.20161.
53. Poljak M, Kocjan BJ. 2010. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev. Anti Infect. Ther. 8:1139-1162. http://dx.doi.org/10.1586/eri.10.104.
54. Goldstein MA, Goodman A, del Carmen MG, Wilbur DC. 2009. Case records of the Massachusetts General Hospital. Case 10-2009-a 23-yearold woman with an abnormal Papanicolaou smear. N. Engl. J. Med. 360: 1337-1344. http://dx.doi.org/10.1056/NEJMcpc0810837.
55. Goldman B, Rebolj M, Rygaard C, Preisler S, Ejegod DM, Lynge E, Bonde J. 2013. Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark. Vaccine 31: 1604-1609. http://dx.doi.org/10.1016/j.vaccine.2012.12.084.
56. Mejlhede N, Pedersen BV, Frisch M, Fomsgaard A. 2010. Multiple human papilloma virus types in cervical infections: competition or synergy? APMIS 118:346-352. http://dx.doi.org/10.1111/j.1600-0463.2010.2602.x.
57. Asiaf A, Ahmad ST, Mohammad SO, Zargar MA. 14 October 2013. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur. J. Cancer Prev. http://dx.doi.org/10.1097/CEJ.0b013e328364f273.
58. Pons-Salort M, Letort V, Favre M, Heard I, Dervaux B, Opatowski L, Guillemot D. 2013. Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach. Vaccine 31:1238-1245. http://dx.doi.org/10.1016/j.vaccine.2012.11.098.
59. Auvert B, Marais D, Lissouba P, Zarca K, Ramjee G, Williamson AL. 2011. High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers. Infect. Dis. Obstet. Gynecol. 2011:692012. http://dx.doi.org/10.1155/2011/692012.
60. Marais DJ, Carrara H, Ramjee G, Kay P, Williamson AL. 2009. HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers. J. Med. Virol. 81:203-210. http://dx.doi.org/10.1002/jmv.21343.
61. Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, Dermody TS, Pfeiffer JK. 2011. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334:249-252. http://dx.doi.org/10.1126/science.1211057.
62. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV, Golovkina TV. 2011. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334:245-249. http://dx.doi.org/10.1126/science.1210718.
63. Jenkins D. 2008. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol. Oncol. 110:S18-S25. http://dx.doi.org/10.1016/j.ygyno.2008.06.027.